As U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the number of ...

Among privately insured U.S. adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers ...

The GOP has tried and failed to pass a ban on puberty blockers and hormone treatments, as well as gender-affirming surgery, ...

The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...

It is time for the female members of Congress to take a stand on behalf of women and girls. They should start by supporting Nancy Mace.

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...

A new study found less than .1% of transgender and gender-diverse teens are prescribed puberty blockers or gender-affirming ...

The study finds that despite fears of their over-medicalization, transgender adolescents are only very rarely prescribed ...

A study by Harvard Chan School researches shows puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse adolescents, countering concerns among ...

Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents, according to a new study from researchers at Harvard T.H. Chan School of ...